Tuesday, April 10, 2007
Research Report on Array BioPharma (ARRY)
WR Hamrecht has a research report on ARRY (the company the produces AZD6244) which shows there is significant momentum around the success of this drug. In fact the target price was almost doubled in November based on potential of AZD6244 and the results of the trial my father is participating in.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment